Study for the Cengage Microbiology Test with helpful multiple choice questions and detailed explanations. Ace your exam with confidence!

Multiple Choice

The treatment of necrotizing skin and soft tissue infections usually requires:

Necrotizing skin and soft tissue infections require immediate source control plus antimicrobial therapy. The dead, necrotic tissue acts as a breeding ground for bacteria and impedes antibiotic penetration, while toxins released by certain organisms drive rapid tissue destruction and systemic illness. Surgical debridement removes the devitalized tissue, limits the spread of infection, and reduces the bacterial load, which is essential for stopping the progression. At the same time, broad-spectrum antibiotics are needed to treat the wide range of possible organisms (covering Gram-positives, including MRSA and streptococci; Gram-negatives; and anaerobes) and to support the patient’s systemic infection. In many cases, clindamycin is added when there is suspicion of toxin-producing organisms like group A Streptococcus to help suppress toxin production. Observation or antibiotics alone won’t remove necrotic tissue or halt toxin-mediated damage, and debridement alone won’t address the remaining bacteria and toxins. The best approach combines urgent surgical debridement with broad-spectrum intravenous antibiotics, started promptly and tailored as cultures return.

Necrotizing skin and soft tissue infections require immediate source control plus antimicrobial therapy. The dead, necrotic tissue acts as a breeding ground for bacteria and impedes antibiotic penetration, while toxins released by certain organisms drive rapid tissue destruction and systemic illness. Surgical debridement removes the devitalized tissue, limits the spread of infection, and reduces the bacterial load, which is essential for stopping the progression. At the same time, broad-spectrum antibiotics are needed to treat the wide range of possible organisms (covering Gram-positives, including MRSA and streptococci; Gram-negatives; and anaerobes) and to support the patient’s systemic infection. In many cases, clindamycin is added when there is suspicion of toxin-producing organisms like group A Streptococcus to help suppress toxin production. Observation or antibiotics alone won’t remove necrotic tissue or halt toxin-mediated damage, and debridement alone won’t address the remaining bacteria and toxins. The best approach combines urgent surgical debridement with broad-spectrum intravenous antibiotics, started promptly and tailored as cultures return.